Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III).

Vascular radiation in a drug-eluting stent world: it's not over till it's over.

Intravascular brachytherapy for native coronary ostial in-stent restenotic lesions.

Implications of the presence and length of "geographic miss" on restenosis and the edge phenomenon in the INHIBIT trial.

Pilot trial of oral rapamycin for recalcitrant restenosis.

Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies.

Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention.

Long-term outcome of patients treated with repeat percutaneous coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosis.

Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus.

A case of an entrapped rotational atherectomy burr.